Health Catalyst, Inc.
HCAT
$1.10
-$0.12-9.50%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -340.31% | -50.95% | -203.18% | -15.33% | 31.80% |
| Total Depreciation and Amortization | 22.10% | 25.81% | 15.88% | 15.94% | -5.34% |
| Total Amortization of Deferred Charges | 14.71% | 5.18% | 44.81% | 47.82% | 48.37% |
| Total Other Non-Cash Items | 850.33% | 82.74% | 240.10% | -44.32% | -26.74% |
| Change in Net Operating Assets | 129.47% | -298.81% | -156.53% | -55.13% | 71.42% |
| Cash from Operations | 381.03% | -107.47% | -658.13% | -97.27% | 81.48% |
| Capital Expenditure | 33.90% | 63.83% | 179.31% | -222.12% | -61.96% |
| Sale of Property, Plant, and Equipment | 333.33% | 100.00% | 350.00% | 133.33% | -70.00% |
| Cash Acquisitions | 100.00% | 100.00% | 100.04% | -- | -122.86% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 101.46% | -120.42% | -405.80% | 64.57% | -309.25% |
| Cash from Investing | 100.89% | -222.33% | -2,829.05% | 15.21% | -476.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -30.03% | -65.79% | -- | -- | -- |
| Issuance of Common Stock | -- | -20.18% | -55.87% | -19.47% | -11.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -101.15% | -100.48% | -33,065.47% | -646.00% | 9,441.77% |
| Foreign Exchange rate Adjustments | 122.92% | -163.86% | 3,350.00% | 63.16% | -382.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 113.36% | -108.23% | -55,577.33% | -2.91% | -795.99% |